From Genomes to Protective Antigens--Designing Vaccines (GPADV 2006). Designing improved and novel vaccines in the future. 15-17 November 2006, Prague, Czech Republic.
Cullen
Paul A
PA
Department of Microbiology, Faculty of Medicine, Nursing and Health Sciences, Monash University, Victoria 3800, Australia. paul.cullen@med.monash.edu.au
D016915:AIDS Vaccines / Q000627:therapeutic use; D000818:Animals; D000941:Antigens / Q000627:therapeutic use*; D000954:Antigens, Surface / Q000276:immunology; D019295:Computational Biology; D016208:Databases, Factual; D015195:Drug Design; D023281:Genomics / Q000639:trends*; D006680:HLA Antigens / Q000276:immunology; D006801:Humans; D008213:Lymphocyte Activation / Q000187:drug effects; D009844:Oligosaccharides / Q000276:immunology; D032581:Tuberculosis Vaccines / Q000627:therapeutic use; D014612:Vaccines / Q000627:therapeutic use*; D019444:Vaccines, DNA / Q000276:immunology
D016915:AIDS Vaccines; D000941:Antigens; D000954:Antigens, Surface; D006680:HLA Antigens; D009844:Oligosaccharides; D032581:Tuberculosis Vaccines; D014612:Vaccines; D019444:Vaccines, DNA